m+Medelevator.RU
← Поиск публикаций
Digital health · 2026

MRI radiomics-based machine learning model for complete response classification after chemoradiotherapy in advanced rectal cancer.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Min Jin Young, Park Jun Young, Kim Young Jae, Jeon Youngbae, Kim Kwang Gi, Baek Jeong-Heum

Аннотация

OBJECTIVE: Accurate identification of complete response (CR) after neoadjuvant chemoradiotherapy (NCRT) is essential for selecting candidates for watch-and-wait treatment in advanced rectal cancer. This study aimed to develop and evaluate a magnetic resonance imaging (MRI) radiomics-based machine learning model to classify CR and Non-CR in post-NCRT rectal MRI images.

METHODS: Using region-of-interest masks, 107 radiomic features were extracted and normalized to a 0-1 range using min-max scaling. Four feature selection methods (ANOVA, RFE, SBS, and LASSO) were paired with four classifiers (LR, SVM, RF, and XGB), and all combinations were evaluated through 5-fold cross-validation in the training set using mean ROC AUC as the comparison metric.

RESULTS: Among 16 combinations, RFE + SVM achieved the highest cross-validation AUC of 0.89. On an independent test set, the model achieved a sensitivity of 0.84, specificity of 0.80, accuracy of 0.82, and F1-score of 0.82. The most informative features were intensity and local texture features, including TotalEnergy, 10Percentile, Coarseness, Strength, Correlation, ZoneEntropy, and Idmn.

CONCLUSIONS: MRI radiomics combined with machine learning shows preliminary promise as an exploratory approach for classifying CR and Non-CR after NCRT in rectal cancer. Given the retrospective, single-center design and the absence of external validation, these findings should be interpreted as preliminary, and prospective multicenter validation is required before clinical implementation. A multicenter external validation integrating endoscopy and digital rectal examination findings is planned to enhance generalizability and clinical utility.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты